Tidemark’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Tidemark's PCRX Position: Q3 2026 in Review
Tidemark held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 2,169 shares worth $54.3K. The position accounts for 0.01% of the portfolio, ranked #317.
Tidemark first reported a position in PCRX in Q3 2025 and has held it in 5 quarters since. The position peaked at $56.1K in Q4 2025. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Tidemark held 2,169 shares of Pacira BioSciences worth $54.3K as of Q3 2026.
- Tidemark left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up 0.01% of Tidemark's portfolio in Q3 2026, its #317 holding.
- Tidemark first reported a position in Pacira BioSciences in Q3 2025 and has held it in 5 quarters since.
- Tidemark's Pacira BioSciences position peaked at $56.1K in Q4 2025.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Tidemark's 13F filing for Q3 2026, filed 9 Nov 2026.